KR920019365A - 디리트로마이신을 함유하는 약학 제형 - Google Patents

디리트로마이신을 함유하는 약학 제형 Download PDF

Info

Publication number
KR920019365A
KR920019365A KR1019920007117A KR920007117A KR920019365A KR 920019365 A KR920019365 A KR 920019365A KR 1019920007117 A KR1019920007117 A KR 1019920007117A KR 920007117 A KR920007117 A KR 920007117A KR 920019365 A KR920019365 A KR 920019365A
Authority
KR
South Korea
Prior art keywords
pharmaceutical formulations
formulations containing
dirithromycin
containing dirithromycin
tablet
Prior art date
Application number
KR1019920007117A
Other languages
English (en)
Other versions
KR100193742B1 (ko
Inventor
마이클 그린 제임스
마리 핸킨스 홀리
알란 스테펜슨 그레고리
데일 위쓰 데이비드
Original Assignee
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 일라이 릴리 앤드 캄파니 filed Critical 일라이 릴리 앤드 캄파니
Publication of KR920019365A publication Critical patent/KR920019365A/ko
Application granted granted Critical
Publication of KR100193742B1 publication Critical patent/KR100193742B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

내용 없음

Description

디리트로마이신을 함유하는 약학 제형
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 활성성분으로서의 디리트로마이신 형태 Ⅱ를 하나 이상의 약학적으로 허용되는 부형제와 함께 함유하는 정제.
  2. 제1항에 있어서, 위액에 대해 내성을 갖는 하나 이상의 층으로 코팅된 정제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920007117A 1991-04-29 1992-04-27 디리트로마이신을 함유하는 약학 제형 KR100193742B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29
US692,842 1991-04-29

Publications (2)

Publication Number Publication Date
KR920019365A true KR920019365A (ko) 1992-11-19
KR100193742B1 KR100193742B1 (ko) 1999-06-15

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1019920007117A KR100193742B1 (ko) 1991-04-29 1992-04-27 디리트로마이신을 함유하는 약학 제형
KR1019920007116A KR100194307B1 (ko) 1991-04-29 1992-04-27 약학적화합물

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1019920007116A KR100194307B1 (ko) 1991-04-29 1992-04-27 약학적화합물

Country Status (27)

Country Link
EP (2) EP0511800B1 (ko)
JP (2) JP3135672B2 (ko)
KR (2) KR100193742B1 (ko)
CN (2) CN1030611C (ko)
AT (2) ATE138924T1 (ko)
AU (2) AU655978B2 (ko)
BR (2) BR9201540A (ko)
CA (2) CA2067275C (ko)
CY (2) CY1946A (ko)
CZ (2) CZ282021B6 (ko)
DE (2) DE69214710T2 (ko)
DK (2) DK0511800T3 (ko)
ES (2) ES2093779T3 (ko)
FI (2) FI921876A (ko)
GR (2) GR3020439T3 (ko)
HK (2) HK153696A (ko)
HU (2) HU213613B (ko)
IE (2) IE74885B1 (ko)
IL (2) IL101705A (ko)
MX (2) MX9201946A (ko)
MY (2) MY109498A (ko)
NO (2) NO179504C (ko)
NZ (2) NZ242505A (ko)
RU (2) RU2070203C1 (ko)
TW (2) TW216399B (ko)
YU (2) YU44492A (ko)
ZA (2) ZA922776B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (ko) * 1992-07-30 1996-03-01 Pfizer
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
ES2173057T3 (es) * 1996-07-29 2004-11-16 Abbott Laboratories Preparacion de la forma ii cristalina de claritromicina.
HUP9904065A3 (en) * 1996-09-24 2001-10-29 Lilly Co Eli Coated particle formulations containing olanzapine
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
CA2670482C (en) * 2006-12-05 2011-10-11 Pfizer Inc. Motilide polymorphs
CN102145008B (zh) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 一种地红霉素药物组合物及其制备方法
CN107151261B (zh) * 2017-06-09 2020-06-12 广州大光制药有限公司 一种地红霉素化合物的晶型及其结晶制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
KR100193742B1 (ko) 1999-06-15
FI921876A (fi) 1992-10-30
HU9201398D0 (en) 1992-07-28
IE76296B1 (en) 1997-10-08
NO179504B (no) 1996-07-15
CN1066186A (zh) 1992-11-18
CY1946A (en) 1992-04-27
DE69211220T2 (de) 1996-11-07
HK215096A (en) 1996-12-13
IL101705A0 (en) 1992-12-30
NZ242505A (en) 1993-06-25
YU44492A (sh) 1994-06-24
ATE144425T1 (de) 1996-11-15
MX9201946A (es) 1992-11-01
ATE138924T1 (de) 1996-06-15
MY109498A (en) 1997-02-28
BR9201541A (pt) 1992-12-01
CN1030611C (zh) 1996-01-03
NO180450C (no) 1997-04-23
GR3020439T3 (en) 1996-10-31
KR100194307B1 (ko) 1999-06-15
NO180450B (no) 1997-01-13
JPH05117154A (ja) 1993-05-14
DK0511799T3 (da) 1996-06-24
NO921617L (no) 1992-10-30
CA2067275A1 (en) 1992-10-30
KR920019364A (ko) 1992-11-19
JP3333545B2 (ja) 2002-10-15
NO921616L (no) 1992-10-30
EP0511799A1 (en) 1992-11-04
TW216399B (ko) 1993-11-21
EP0511800A1 (en) 1992-11-04
HU213613B (en) 1997-08-28
AU1525592A (en) 1992-11-05
BR9201540A (pt) 1992-12-01
AU655978B2 (en) 1995-01-19
IL101705A (en) 1996-01-31
RU2045953C1 (ru) 1995-10-20
FI921877A0 (fi) 1992-04-27
FI921876A0 (fi) 1992-04-27
EP0511800B1 (en) 1996-10-23
EP0511799B1 (en) 1996-06-05
AU1525792A (en) 1992-11-05
CS127692A3 (en) 1992-11-18
HUT63956A (en) 1993-11-29
AU646734B2 (en) 1994-03-03
RU2070203C1 (ru) 1996-12-10
IL101704A0 (en) 1992-12-30
MX9201944A (es) 1992-11-01
CZ282218B6 (cs) 1997-06-11
NO921616D0 (no) 1992-04-27
GR3021706T3 (en) 1997-02-28
CA2067274A1 (en) 1992-10-30
CN1066270A (zh) 1992-11-18
CZ282021B6 (cs) 1997-04-16
HK153696A (en) 1996-08-16
DE69211220D1 (de) 1996-07-11
ZA922777B (en) 1993-10-15
HU9203168D0 (en) 1992-12-28
TW315371B (ko) 1997-09-11
ES2093779T3 (es) 1997-01-01
JPH05117289A (ja) 1993-05-14
DK0511800T3 (da) 1997-04-21
HUT62595A (en) 1993-05-28
CS127792A3 (en) 1992-11-18
FI921877A (fi) 1992-10-30
CN1069197C (zh) 2001-08-08
ES2088098T3 (es) 1996-08-01
FI101795B (fi) 1998-08-31
FI101795B1 (fi) 1998-08-31
ZA922776B (en) 1993-10-15
HU215917B (hu) 1999-03-29
IE921345A1 (en) 1992-11-04
IE74885B1 (en) 1997-08-13
IL101704A (en) 1998-02-22
DE69214710T2 (de) 1997-03-13
DE69214710D1 (de) 1996-11-28
CY1975A (en) 1997-09-05
NO921617D0 (no) 1992-04-27
NZ242506A (en) 1993-09-27
IE921346A1 (en) 1992-11-04
YU44392A (sh) 1994-12-28
CA2067274C (en) 2002-10-15
MY114226A (en) 2002-09-30
NO179504C (no) 1996-10-23
JP3135672B2 (ja) 2001-02-19
CA2067275C (en) 2002-11-26

Similar Documents

Publication Publication Date Title
ES2083668T3 (es) Combinaciones antiviricas que contienen analogos de nucleosidos.
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9205981A (es) Administracion transdermica de melatonina.
FI913248A0 (fi) Kontrollerat frigoerande fast farmaceutisk doseringsform.
SE8300736D0 (sv) Novel pharmacologically active compounds
KR870005637A (ko) 약물 데포
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
KR890015742A (ko) 이병치료용 국소 제제
KR920017655A (ko) 상처의 치료를 촉진시키기 위한 약학 조성물
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
ITRM910002A1 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
DZ1559A1 (fr) Compositions pharmaceutiques.
KR920019365A (ko) 디리트로마이신을 함유하는 약학 제형
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
ES2171459T3 (es) Polvo para administracion nasal de farmaco peptidico o proteinaceo.
NO892764L (no) Medikamentell administreringsform for droevtyggere.
DE68905171T2 (de) Benzol-derivate, ihre herstellung und pharmazeutische zusammensetzungen, die diese enthalten.
DE69101145D1 (de) (alkylthio-3-propyl)-3-benzothiazolinderivate, ihre herstellung und diese enthaltende arzneimittel.
IT1244373B (it) Composizioni farmaceutiche per uso orale contenenti eparina a basso peso molecolare, loro preparazione ed uso
ATE165239T1 (de) Orale arzeimittelzubereitung enthaltend diclofenac-natrium und eine organische säure
LV10917A (lv) Bambuterina pielietojums lipidu saturu pazeminosu farmaceitisku kompoziciju pagatavosanai
KR930004460A (ko) 에이(a) 87689 화합물
ATE74505T1 (de) Schmerzpraeparat.
MX9205375A (es) Nuevos derivados de bencilamina y el medicamento que los contienen.
KR950007852A (ko) 우라실을 유효성분으로 함유하는 관절염 치료제

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20070108

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee